Certara

Certara utilizes proprietary biosimulation software and technology to accelerate drug development, transforming traditional drug discovery and development. Its clients include 1,650 global biopharmaceutical companies, leading academic institutions, and major regulatory agencies across 61 countries and regions. Certara's solutions cover the discovery, preclinical, and clinical stages of drug development, enabling data-driven decision-making, which leads to more precisely designed trials, reducing the risk of failure and enhancing the safety of participants.